A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798) (Q80149334)
Jump to navigation
Jump to search
scientific article published on 04 December 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798) |
scientific article published on 04 December 2007 |
Statements
A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798) (English)
Knox JJ
Chen XE
Feld R
Nematollahi M
Cheiken R
Pond G
Zwiebel JA
Gill S
4 December 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference